Coherus Oncology (CHRS) EPS (Basic) Growth (3y) (2016 - 2026)
Coherus Oncology (CHRS) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Coherus Oncology | 195.05 Mn | 28.00 Mn | 8.50 Mn | 77.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.98% |
| Dec 31, 2025 | 28.02% |
| Sep 30, 2025 | 27.43% |
| Jun 30, 2025 | 87.24% |
| Mar 31, 2025 | 60.07% |
| Dec 31, 2024 | 59.51% |
| Sep 30, 2024 | 38.49% |
| Jun 30, 2024 | 42.98% |
| Mar 31, 2024 | 38.18% |
| Dec 31, 2023 | -101.84% |
| Sep 30, 2023 | -47.65% |
| Jun 30, 2023 | -39.20% |
| Mar 31, 2023 | -58.72% |
| Dec 31, 2022 | -50.56% |
| Sep 30, 2022 | -55.61% |
| Jun 30, 2022 | -58.77% |
| Mar 31, 2022 | -62.60% |
| Dec 31, 2021 | 14.32% |
| Sep 30, 2021 | 17.46% |
| Jun 30, 2021 | 16.63% |